- Home
- INZY vs LFVN Comparison
INZY vs LFVN Comparison
Compare INZY & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- LFVN
- Stock Information
- Founded
- INZY 2015
- LFVN N/A
- Country
- INZY United States
- LFVN United States
- Employees
- INZY N/A
- LFVN N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- INZY Health Care
- LFVN Health Care
- Exchange
- INZY Nasdaq
- LFVN Nasdaq
- Market Cap
- INZY 165.1M
- LFVN 188.1M
- IPO Year
- INZY 2020
- LFVN N/A
- Fundamental
- Price
- INZY $2.73
- LFVN $15.35
- Analyst Decision
- INZY Strong Buy
- LFVN
- Analyst Count
- INZY 7
- LFVN 0
- Target Price
- INZY $16.14
- LFVN N/A
- AVG Volume (30 Days)
- INZY 871.3K
- LFVN 87.1K
- Earning Date
- INZY 11-05-2024
- LFVN 01-28-2025
- Dividend Yield
- INZY N/A
- LFVN 0.92%
- EPS Growth
- INZY N/A
- LFVN 59.77
- EPS
- INZY N/A
- LFVN 0.32
- Revenue
- INZY N/A
- LFVN $196,014,000.00
- Revenue This Year
- INZY N/A
- LFVN $4.36
- Revenue Next Year
- INZY N/A
- LFVN $3.85
- P/E Ratio
- INZY N/A
- LFVN $48.04
- Revenue Growth
- INZY N/A
- LFVN N/A
- 52 Week Low
- INZY $2.39
- LFVN $5.22
- 52 Week High
- INZY $7.80
- LFVN $17.49
- Technical
- Relative Strength Index (RSI)
- INZY 41.48
- LFVN 55.79
- Support Level
- INZY $2.84
- LFVN $14.51
- Resistance Level
- INZY $3.28
- LFVN $17.49
- Average True Range (ATR)
- INZY 0.25
- LFVN 1.15
- MACD
- INZY 0.10
- LFVN 0.09
- Stochastic Oscillator
- INZY 48.84
- LFVN 41.69
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.